Uniphar (DUB:UPR) Retained Earnings: €200 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

DUB:UPR Uniphar PLC DUB:UPR
82 GF Score
Price €4.55
GF Value €3.65
Valuation Modestly Overvalued
! 9 Warning Signs
View Full Analysis

What is Uniphar Retained Earnings?

Uniphar DUB:UPR -2.57% 82 Retained Earnings is €200 Mil as of Dec. 2025. GuruFocus rates DUB:UPR with a GF Score™ of 82/100 and a GF Value™ of €3.65 (Modestly Overvalued). The stock has 9 warning signs investors should review.

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Uniphar's retained earnings for the quarter that ended in Dec. 2025 was €200 Mil.

Uniphar's quarterly retained earnings declined from Dec. 2024 (€189 Mil) to Jun. 2025 (€168 Mil) but then increased from Jun. 2025 (€168 Mil) to Dec. 2025 (€200 Mil).

Uniphar's annual retained earnings increased from Dec. 2023 (€128 Mil) to Dec. 2024 (€189 Mil) and increased from Dec. 2024 (€189 Mil) to Dec. 2025 (€200 Mil).


Uniphar  (DUB:UPR) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.


Uniphar Retained Earnings Historical Data

* Premium members only.

The historical data trend for Uniphar's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Uniphar Retained Earnings Chart

Uniphar Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Retained Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only 47.56 88.48 128.21 188.62 199.89

Uniphar Semi-Annual Data
Dec16 Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Retained Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 128.21 141.04 188.62 168.11 199.89
DUB:UPR
82GF Score
Uniphar PLC DUB:UPR
Retained Earnings is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Uniphar Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.

Frequently Asked Questions Learn more about Retained Earnings →
What does a Retained Earnings of €200 Mil mean?
Uniphar (DUB:UPR) has a Retained Earnings of €200 Mil as of Dec. 2025. Retained earnings is the amount of net income not issued to shareholders. View historical data on Uniphar and its competitors.
Is Uniphar's Retained Earnings too high?
Uniphar's current Retained Earnings is €200 Mil. Overall, Uniphar has a GF Score™ of 82/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Uniphar's Retained Earnings compare to MCK and CAH?
Uniphar's Retained Earnings of €200 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Retained Earnings for a Medical Distribution company?
A good Retained Earnings depends on the Medical Distribution industry context. However, Retained Earnings should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Retained Earnings mean?
A high Retained Earnings can signal that a stock is expensive relative to its fundamentals. Retained earnings is the amount of net income not issued to shareholders. View historical data on Uniphar and its competitors. Uniphar's current Retained Earnings is €200 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Uniphar stock overvalued right now?
Based on GuruFocus' analysis, Uniphar (DUB:UPR) is currently considered Modestly Overvalued. The stock's GF Value™ is €3.65, compared to a current price of €4.55 — trading 24.7% above its estimated fair value. The current Retained Earnings is €200 Mil. Uniphar's overall GF Score™ is 82/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Retained Earnings calculated?
Retained Earnings is calculated from a company's financial statements. For Uniphar (DUB:UPR), the current Retained Earnings is €200 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Uniphar (DUB:UPR) Overvalued in 2026?

Based on GuruFocus' analysis, Uniphar stock appears to be overvalued. The current stock price of €4.55 is trading 24.7% above its estimated GF Value™ of €3.65. GuruFocus considers Uniphar to be Modestly Overvalued.

Key valuation signals for DUB:UPR:

  • Retained Earnings: €200 Mil
  • GF Value™: €3.65 vs. price of €4.55 (24.7% above fair value)
  • GF Score™: 82/100 with 9 warning signs

No single metric tells the full story. See the DUB:UPR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Uniphar Business Description

Other Exchanges UPR:UK0NR:Germany
Address 4045 Kingswood Road, Citywest Business Park, Dublin, IRL, D24 V06K
Uniphar PLC is a service provider within the pharmaceutical and healthcare sector. The company is an international diversified healthcare services business servicing the requirements of multinational pharmaceutical and medical technology manufacturers across three divisions - Uniphar Pharma, Uniphar Medtech and Uniphar Supply Chain & Retail. Uniphar Pharma enables pharma and biotech companies to bring medicines to markets globally and provide healthcare professionals with access to medicines that can't be sourced through traditional channels. Uniphar Medtech is a Pan-European medical device distributor and solutions partner. Uniphar Supply Chain & Retail is the pharmaceutical wholesaler in Ireland offering of retail pharmacies.
82GF Score

Get the complete analysis for DUB:UPR

Retained Earnings is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.55
Price
€3.65
GF Value